P53 gene therapy (Regulon)

N/A

Report date: 2023/12/18 18:09:15

Base Information

Drug NameP53 gene therapy (Regulon)
Drug Alias NameLipoRp53
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionTumor protein p53 modulators
TargetsTumor protein p53
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesRegulon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegulon
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A